We are live on ! Find out more
CRDS

Crossroads Systems, Inc.
CRDS

Delisted

CRDS was delisted on the 22nd of August, 2017.

14 hedge funds and large institutions have $537K invested in Crossroads Systems, Inc. in 2016 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more funds holding

Funds holding: 914 (+5)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

61% less capital invested

Capital invested by funds: $1.39M → $537K (-$853K)

Holders
14
Holders Change
+5
Holders Change %
+55.56%
% of All Funds
0.35%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
1
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

CRDS Hedge Fund Activity: Q4 2016 in Review

14 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Crossroads Systems, Inc. (CRDS) for Q4 2016, worth a combined $537K — down 61% from $1.39M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new CRDS positions and 0 closed out — a net gain of 6 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Vanguard Group, opening a new position worth an estimated $89.7K. The largest seller was Tower Research Capital (TRC), cutting an estimated $541.

  • 14 institutional investors held Crossroads Systems, Inc. (CRDS) as of Q4 2016, up from 9 in Q3 2016.
  • Funds reported $537K of Crossroads Systems, Inc. stock for Q4 2016, down 61% quarter-over-quarter.
  • 6 funds opened new Crossroads Systems, Inc. positions in Q4 2016 and 0 closed out, a net change of +6 holders.
  • The largest Crossroads Systems, Inc. buyer in Q4 2016 was Vanguard Group, an estimated $89.7K added.
  • The largest Crossroads Systems, Inc. seller in Q4 2016 was Tower Research Capital (TRC), an estimated $541 sold.

Based on aggregated 13F filings for Q4 2016.